DCOY insider trading
NasdaqCM HealthcareDECOY THERAPEUTICS INC: insider trade history from SEC Form 4 filings.
About DECOY THERAPEUTICS INC
Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts.
Company website: decoytx.com
DCOY insider activity at a glance
FilingIQ tracks 10 insider transactions for DCOY in filings since Sep 2, 2026. The most recent transaction is dated Aug 31, 2026.
Across the full history, 0 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest DCOY Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for DCOY?
- FilingIQ tracks 10 Form 4 insider transactions for DCOY (DECOY THERAPEUTICS INC), covering filings from Sep 2, 2026 onwards. 10 of those are dated within the last 90 days.
- Are DCOY insiders net buyers or net sellers?
- Across the full Form 4 history for DCOY, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does DCOY insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is DCOY in?
- DECOY THERAPEUTICS INC (DCOY) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.74M.
Methodology & sources
Every DCOY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.